Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis

C D Applegate1, L H Tecott

  • 1Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, 14642, USA. capplegate@mail.neurology.edu

Experimental Neurology
|January 8, 1999
PubMed

Insights

Mice lacking the serotonin 5-HT2C receptor show increased seizure susceptibility. Blocking this receptor in normal mice mimics this epilepsy phenotype, highlighting its role in controlling seizures.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Previous research indicates that mice with a disrupted 5-HT2C receptor gene develop epilepsy with spontaneous seizures.
  • The 5-HT2C receptor plays a role in neurological function, but its specific impact on seizure susceptibility requires further definition.

Purpose of the Study:

  • To characterize the seizure susceptibility profiles of 5-HT2C receptor mutant mice.
  • To investigate the role of the 5-HT2C receptor in modulating neuronal excitability and seizure propagation.

Main Methods:

  • 5-HT2C receptor mutant mice and wild-type controls were subjected to various seizure induction methods: electrical kindling, corneal electroshock, and chemoconvulsant (flurothyl) administration.
  • The effects of the 5-HT2C receptor antagonist, mesulergine, were evaluated in wild-type mice.

Main Results:

  • Mice lacking the 5-HT2C receptor exhibited significantly higher seizure susceptibility across all tested paradigms compared to wild-type controls.
  • Mutant mice displayed lower focal seizure thresholds, increased focal seizure excitability, and enhanced seizure propagation.
  • Lower generalized seizure thresholds for both clonic and tonic seizures were observed in mutant mice.
  • Administration of mesulergine to wild-type mice replicated the heightened seizure susceptibility seen in the mutant mice.

Conclusions:

  • The 5-HT2C receptor is crucial for modulating neuronal network excitability and controlling seizure propagation throughout the central nervous system.
  • Serotonin signaling via 5-HT2C receptors represents a potential therapeutic target for epilepsy management.

Related Concept Videos